Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Treatment in Type 1 Diabetes in a Tertiary Care Center in Saudi Arabia

Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Treatment in Type 1 Diabetes in a Tertiary Care Center in Saudi Arabia

Background Adjunctive treatment with sodium-glucose co-transporters 2 inhibitors (SGLT2- I) has been successfully used in patients with type 1 diabetes mellitus (T1DM) in recent years to improve glycemic control and reduce body weight without increasing the risk of hypoglycemia; however, there is a...

Full description

Bibliographic Details
Main Authors: Walla Fallatah, Imad Brema, Ahmed Alobedallah, Reem Alkhathami, Shawana Zaheer, Eyad AlMalki, Mohammed Almehthel, Saad Alzahrani, Mussa H. AlMalki
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-01-01
Series:Avicenna Journal of Medicine
Subjects:
type 1 diabetes mellitus
sodium-glucose co-transporter 2 inhibitors
glycemic control
weight gain
diabetic ketoacidosis
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1742196

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1742196

Similar Items